Improved survival rates of AML patients following admission to the intensive care unit

References

• Blijlevens NM, Donnelly JP, De Pauw BE. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant. 2000;25:1269–1278.
   PubMed Web of Science ®Google Scholar
• Schellongowski P, Staudinger T, Kundi M, et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica. 2011;96:231–237.
   PubMed Web of Science ®Google Scholar
• Atallah E, Cortes J, O'Brien S, et al. Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia. Blood. 2007;110:3547–3551.
   PubMed Web of Science ®Google Scholar
• Bird GT, Farquhar-Smith P, Wigmore T, et al. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Br J Anaesth. 2012;108:452–459.
   PubMed Web of Science ®Google Scholar
• Groeger JS, White P, Jr, Nierman DM, et al. Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol. 1999;17:991–997.
   PubMed Web of Science ®Google Scholar
• Bos MM, de Keizer NF, Meynaar IA, et al. Outcomes of cancer patients after unplanned admission to general intensive care units. Acta Oncol. 2012;51:897–905.
   PubMed Web of Science ®Google Scholar
• Moran JL, Solomon PJ, Outcome ACF. Resource evaluation of the A, New Zealand Intensive Care S. Mortality and intensive care volume in ventilated patients from 1995 to 2009 in the Australian and New Zealand binational adult patient intensive care database. Crit Care Med. 2012;40:800–812.
   PubMed Web of Science ®Google Scholar
• Hill QA. Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy. Blood Rev. 2010;24:17–25.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med. 2006;32:3–5.
   PubMed Web of Science ®Google Scholar
• Souza-Dantas VC, Salluh JI, Soares M. Impact of neutropenia on the outcomes of critically ill patients with cancer: a matched case-control study. Ann Oncol. 2011;22:2094–2100.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Soares M, Darmon M, et al. Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care. 2011;1:5–7.
   PubMed Web of Science ®Google Scholar
• Fridle C, Medinger M, Wilk MC, et al. Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML). Leuk Lymphoma. 2017;58:1068–1075.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic trials in Acute Myeloid Leukemia. J Clin Oncol. 2003;21:4642–4649.
   PubMed Web of Science ®Google Scholar
• Le Gall J-R, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–2963.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Mokart D, Pene F, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium - a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol. 2013;31:2810–2818.
   PubMed Web of Science ®Google Scholar
• Thiéry G, Azoulay E, Darmon M, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol. 2005;23:4406–4413.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Pene F, Darmon M, et al. Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique (Grrr-OH). Managing critically Ill hematology patients: time to think differently. Blood Rev. 2015;29:359–367.
   PubMed Web of Science ®Google Scholar
• Van Vliet M, Verburg IW, Van Den Boogaard M, et al. Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units. Intensive Care Med. 2014;40:1275–1284.
   PubMed Web of Science ®Google Scholar
• Thakkar SG, Fu AZ, Sweetenham JW, et al. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit. Cancer. 2008;112:2233–2240.
   PubMed Web of Science ®Google Scholar
• Rabbat A, Chaoui D, Montani D, et al. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol. 2005;129:350–357.
   PubMed Web of Science ®Google Scholar
• Lengliné E, Raffoux E, Lemiale V, et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma. 2012;53:1352–1359.
   PubMed Web of Science ®Google Scholar
• Ferra C, Marcos P, Misis M, et al. Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience. Inter J Hemat. 2007;85:195–202.
   PubMed Web of Science ®Google Scholar
• Magid T, Haase N, Andersen JS, et al. Intensive care of haematological patients. Dan Med J. 2012;59:A4395.
   PubMed Web of Science ®Google Scholar
• Jackson K, Mollee P, Morris K, et al. Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit. Leuk Lymphoma. 2014;55:97–104.
   PubMed Web of Science ®Google Scholar
• Price KJ, Cardenas-Turanzas M, Lin H, et al. Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center. Minerva Anesthesiologica. 2013;79:147–155.
   PubMed Web of Science ®Google Scholar
• Cornet AD, Issa AI, van de Loosdrecht AA, et al. Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol. 2005;74:511–516.
   PubMed Web of Science ®Google Scholar
• Bird GT, Farquhar-Smith P, Wigmore T, et al. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. Brit J Anaesthesia. 2012;108:452–459.
   PubMed Web of Science ®Google Scholar
• Namendys-Silva SA, Gonzalez-Herrera MO, Garcia-Guillen FJ, et al. Outcome of critically ill patients with hematological malignancies. Ann Hematol. 2013;92:699–705.
   PubMed Web of Science ®Google Scholar
• Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–851.
   PubMed Web of Science ®Google Scholar
• Park HY, Suh GY, Jeon K, et al. Outcome and prognostic factors of patients with acute leukemia admitted to the intensive care unit for septic shock. Leuk Lymphoma. 2008;49:1929–1934.
   PubMed Web of Science ®Google Scholar
• Pène F, Percheron S, Lemiale V, et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med. 2008;36:690–696.
   PubMed Web of Science ®Google Scholar